Immunologist Dr. Satyajit Rath talks about the Omicron variant, which seems to have displaced Delta in India and could infect more people than its predecessor

Immunologist Dr. Satyajit Rath and NewsClick’s Prabir Purkayastha discuss the emerging Omicron situation and new vaccines that have received the emergency use approval in India, including the oral-drug Molnupiravir

The deliberate policy of big pharma and rich countries to leave large populations in poorer countries unvaccinated could plunge the world into another downturn

Dr. Satyajit Rath talks about key aspects of the new drug, Molnupiravir, and points out that a lot that needs attention to make sure the drug becomes accessible to the poorer nations

One year has passed since the TRIPS waiver proposal was first tabled at the World Trade Organization, and rich countries persevere in opposing it. This has affected the availability of vaccines, and is having effect on access to diagnostics and therapeutics too